KratomCBDDirect.com | Kratom CBD Direct

KratomCBDDirect.com | Kratom CBD Direct

7-OH on a Kratom Lab Report: Missing Analytes and Detection Limits

By KratomCBDDirect.com Editorial Team | Sources checked October 6, 2026

This article is educational information, not medical or legal advice. KratomCBDDirect.com is an independent publication. It is not a laboratory, a medical provider, or a government agency. This page contains no affiliate links, product rankings, or purchase links.

When a kratom lab report has a line for 7-OH (7-hydroxymitragynine), the useful question is not only “what is the number?” It is “what kind of answer is this line?” A measured value, a not-detected result, a result below the quantification limit, and a missing row are four different situations. The first three describe the tested sample, and only at the limits the lab states. A missing row tells you nothing about 7-OH.

The short answer: four statuses, four meanings

  • Measured. The report gives a number with units, at or above the lab's quantification limit. It tells you the amount found in that one sample, by that one method, in that one unit. It does not describe other lots, other products, or whether an amount is appropriate for any person.
  • Not detected (ND). The lab's method did not detect the analyte at its stated limit. ND only means something is at or below that limit, and amounts near the limit can still be missed. A Department of Defense data-quality fact sheet explains that when the true amount sits right at the bare detection limit, a non-detect can occur as often as half the time, and it recommends reporting non-detects against the higher limit of detection (DoD EDQW Detection and Quantitation Fact Sheet, June 29, 2026). Government laboratory-reporting guidance treats a result below the method detection limit as “not detected” and a result between the detection limit and the reporting limit as “detected, not quantifiable” (California Water Boards ND/DNQ guidance). ND does not mean zero.
  • Detected but below quantification. The lab saw enough signal to say the compound was likely present, but not enough for a reliable number. The DoD fact sheet explains that results between the detection and quantification limits support presence, but their numeric values are estimates. Labs may use different abbreviations as long as they define them, so read the report's legend.
  • Not tested. There is no 7-OH row, or the cell is blank, a dash, or “N/A”. This is silence, not a result. A report can be accurate and still never have looked for 7-OH.

Both guidance documents above come from environmental testing. They show how detection and quantification limits work in general. Kratom labs may use different labels, which is why the report's own legend matters.

An analyte-coverage checklist you can run on any report

Work through the report one analyte at a time. For 7-OH, write down these items in your own notes:

  1. Is there a 7-OH row at all? A report may cover only some alkaloids. If there is no row, record “not tested”. Do not fill the gap with a guess.
  2. Which of the four statuses is it? Measured, not detected, below quantification, or not tested.
  3. What limit sits next to it? Find the detection and quantification limits for 7-OH itself, not limits listed for another analyte or another test panel. Detection and quantification limits depend on the analyte, sample type, method, and specific laboratory (DoD EDQW fact sheet).
  4. What are the units and the denominator? A value may be given as a percent of dry weight, milligrams per gram, milligrams per unit, or a share of the alkaloid fraction. These do not convert into each other without more information. For example, Utah's registration page states its 7-OH requirement as a share of the kratom alkaloid fraction (Utah Department of Agriculture and Food), while the federal proposal discussed below uses weight percent and an absolute milligram amount.
  5. Does the report match the sample in question? Look for a lot or batch number, test dates, the product form, and the lab's name and address. Utah's registration page lists these among the COA elements it requires, along with the method for each test and an ISO/IEC 17025-accredited third-party lab (with an exception for labs working toward accreditation). That is one state's program, not a universal standard.
  6. Is the method named, and can it tell 7-OH from lookalike compounds? One 2026 conference abstract from the University of Mississippi reported that relying only on accurate mass or commonly used transitions produced overlapping peaks and a risk of falsely identifying 7-OH, and that added identification steps were needed to separate it from related compounds (University of Mississippi, ICSB 2026 abstract). An abstract is not a standard, but it shows why the method line is part of the answer.

A one-line log for each analyte keeps the four statuses from blurring together:

  • 7-OH: status ______ | limit shown ______ | unit and basis ______ | lot matches ______
  • Mitragynine: status ______ | limit shown ______ | unit and basis ______ | lot matches ______
  • Any other analyte named on the report: same four fields

Why the limit decides whether a 7-OH line is useful

FDA describes 7-OH as a naturally occurring but minor kratom alkaloid, under 2% of total alkaloid content in natural leaf, with much stronger opioid-receptor activity than mitragynine and than classical opioids such as morphine (FDA: FDA and Kratom). Because 7-OH is a small fraction of leaf alkaloids, a lab's limits matter a great deal when a report is trying to say how much is present.

The federal proposal offers a concrete example. In a July 6, 2026 notice of intent, DEA proposed a temporary Schedule I threshold for 7-OH. For kratom plant material, it is more than 0.050% 7-OH on a dry-weight basis. For some processed or synthetic articles, it is more than 0.050% by weight or volume, or more than 1.00 mg of 7-OH in the article (Federal Register, 91 FR 40917). For scale, 0.050% is 0.5 mg per gram. This is a proposal described in a notice, and its status can change, so check the Federal Register for the current position.

Here are two invented examples, not taken from any real report, showing how limits change what a line can tell you:

  • A report says “7-OH: ND” with a stated limit of 0.010%. The method did not detect 7-OH at that limit in that sample. That says something about that one sample, with the caution above that amounts near a limit can be missed. It says nothing about other lots, and it does not show that 7-OH is absent.
  • A report says “7-OH: below quantification” with a quantification limit of 0.20%. The true value could sit anywhere under that limit, including above and below 0.050%. This line cannot place the sample relative to that percentage.

These examples only illustrate how limits work. They are not a way to judge whether any product is legal or appropriate.

The same logic applies to basis. The notice specifies a dry-weight basis for plant material. A report that does not say whether it reports on an as-received or dry basis leaves that comparison open. The DoD fact sheet notes that limits should be adjusted for sample-specific factors such as dilution and percent moisture.

What this checklist can and cannot establish

It can show you what a report says and does not say about 7-OH, and it can show you where the gaps are.

It cannot establish any of the following:

  • That “not detected” means zero, absent, or safe.
  • That one report describes every lot or every product from the same source.
  • That a result for natural leaf applies to a concentrated product. FDA's under-2% figure describes natural leaf. The federal agencies have said their 7-OH actions target concentrated and synthetic products and are not intended for natural leaf with only naturally occurring trace levels (FDA: Hiding in Plain Sight: 7-OH Products, updated July 13, 2026). The notice also observes that products of this kind are often labeled as natural extracts, so a label alone does not show how a product's 7-OH got there.
  • Anything about related compounds that were not tested. On August 26, 2026, DEA published a separate temporary scheduling order for three 7-OH-related substances: mitragynine pseudoindoxyl, MGM-15, and MGM-16 (Federal Register, August 26, 2026). A 7-OH row says nothing about them. Coverage is decided analyte by analyte.
  • Whether a product is legal, appropriate, or safe for any person. FDA states that kratom is not lawfully marketed in the U.S. as a drug, a dietary supplement, or a food additive in conventional food, and has warned about serious adverse events (FDA: FDA and Kratom).

Where professional or regulator input is needed

  • Questions about what a limit or label means: the testing laboratory named on the report is the only party that can explain how it set its limits for that method.
  • Legal status: states differ, and federal action on 7-OH is still developing. FDA advises that state health and law enforcement agencies are the best resource on state law. A licensed attorney can address a specific situation.
  • For health questions or medication interactions, consult a physician or pharmacist. FDA directs people to the Poison Help Line at 1-800-222-1222 if someone may be having a bad reaction to a 7-OH product, and to 911 for a life-threatening event.
  • A bad reaction: FDA asks people to report adverse events through MedWatch.

What is still missing

Even a well-formed report leaves open questions this checklist cannot answer: how the sample was collected, whether other lots differ, how the lab verified its limits, and what any given amount means for a person. Treat every unknown as unknown.

Sources checked October 6, 2026

Related guides

Reader Interactions

Leave a Reply

Your email address will not be published. Required fields are marked *